Cargando…

Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes

BACKGROUND: Greater efforts are needed to overcome the worldwide reported low achievement of LDL-c targets. This survey aimed to dissect whether and how the physician-based evaluation of patients with diabetes is associated with the achievement of LDL-c targets. METHODS: This cross-sectional self-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Morieri, Mario Luca, Lamacchia, Olga, Manzato, Enzo, Giaccari, Andrea, Avogardo, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044595/
https://www.ncbi.nlm.nih.gov/pubmed/35473579
http://dx.doi.org/10.1186/s12933-022-01495-8
_version_ 1784695138204778496
author Morieri, Mario Luca
Lamacchia, Olga
Manzato, Enzo
Giaccari, Andrea
Avogardo, Angelo
author_facet Morieri, Mario Luca
Lamacchia, Olga
Manzato, Enzo
Giaccari, Andrea
Avogardo, Angelo
author_sort Morieri, Mario Luca
collection PubMed
description BACKGROUND: Greater efforts are needed to overcome the worldwide reported low achievement of LDL-c targets. This survey aimed to dissect whether and how the physician-based evaluation of patients with diabetes is associated with the achievement of LDL-c targets. METHODS: This cross-sectional self-reported survey interviewed physicians working in 67 outpatient services in Italy, collecting records on 2844 patients with diabetes. Each physician reported a median of 47 records (IQR 42–49) and, for each of them, the physician specified its perceived cardiovascular risk, LDL-c targets, and the suggested refinement in lipid-lowering-treatment (LLT). These physician-based evaluations were then compared to recommendations from EAS/EASD guidelines. RESULTS: Collected records were mostly from patients with type 2 diabetes (94%), at very-high (72%) or high-cardiovascular risk (27%). Physician-based assessments of cardiovascular risk and of LDL-c targets, as compared to guidelines recommendation, were misclassified in 34.7% of the records. The misperceived assessment was significantly higher among females and those on primary prevention and was associated with 67% lower odds of achieving guidelines-recommended LDL-c targets (OR 0.33, p < 0.0001). Peripheral artery disease, target organ damage and LLT-initiated by primary-care-physicians were all factors associated with therapeutic-inertia (i.e., lower than expected probability of receiving high-intensity LLT). Physician-suggested LLT refinement was inadequate in 24% of overall records and increased to 38% among subjects on primary prevention and with misclassified cardiovascular risk. CONCLUSIONS: This survey highlights the need to improve the physicians’ misperceived cardiovascular risk and therapeutic inertia in patients with diabetes to successfully implement guidelines recommendations into everyday clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01495-8.
format Online
Article
Text
id pubmed-9044595
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90445952022-04-28 Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes Morieri, Mario Luca Lamacchia, Olga Manzato, Enzo Giaccari, Andrea Avogardo, Angelo Cardiovasc Diabetol Research BACKGROUND: Greater efforts are needed to overcome the worldwide reported low achievement of LDL-c targets. This survey aimed to dissect whether and how the physician-based evaluation of patients with diabetes is associated with the achievement of LDL-c targets. METHODS: This cross-sectional self-reported survey interviewed physicians working in 67 outpatient services in Italy, collecting records on 2844 patients with diabetes. Each physician reported a median of 47 records (IQR 42–49) and, for each of them, the physician specified its perceived cardiovascular risk, LDL-c targets, and the suggested refinement in lipid-lowering-treatment (LLT). These physician-based evaluations were then compared to recommendations from EAS/EASD guidelines. RESULTS: Collected records were mostly from patients with type 2 diabetes (94%), at very-high (72%) or high-cardiovascular risk (27%). Physician-based assessments of cardiovascular risk and of LDL-c targets, as compared to guidelines recommendation, were misclassified in 34.7% of the records. The misperceived assessment was significantly higher among females and those on primary prevention and was associated with 67% lower odds of achieving guidelines-recommended LDL-c targets (OR 0.33, p < 0.0001). Peripheral artery disease, target organ damage and LLT-initiated by primary-care-physicians were all factors associated with therapeutic-inertia (i.e., lower than expected probability of receiving high-intensity LLT). Physician-suggested LLT refinement was inadequate in 24% of overall records and increased to 38% among subjects on primary prevention and with misclassified cardiovascular risk. CONCLUSIONS: This survey highlights the need to improve the physicians’ misperceived cardiovascular risk and therapeutic inertia in patients with diabetes to successfully implement guidelines recommendations into everyday clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01495-8. BioMed Central 2022-04-26 /pmc/articles/PMC9044595/ /pubmed/35473579 http://dx.doi.org/10.1186/s12933-022-01495-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Morieri, Mario Luca
Lamacchia, Olga
Manzato, Enzo
Giaccari, Andrea
Avogardo, Angelo
Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes
title Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes
title_full Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes
title_fullStr Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes
title_full_unstemmed Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes
title_short Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes
title_sort physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low ldl-cholesterol targets achievement in diabetes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044595/
https://www.ncbi.nlm.nih.gov/pubmed/35473579
http://dx.doi.org/10.1186/s12933-022-01495-8
work_keys_str_mv AT morierimarioluca physiciansmisperceivedcardiovascularriskandtherapeuticinertiaasdeterminantsoflowldlcholesteroltargetsachievementindiabetes
AT lamacchiaolga physiciansmisperceivedcardiovascularriskandtherapeuticinertiaasdeterminantsoflowldlcholesteroltargetsachievementindiabetes
AT manzatoenzo physiciansmisperceivedcardiovascularriskandtherapeuticinertiaasdeterminantsoflowldlcholesteroltargetsachievementindiabetes
AT giaccariandrea physiciansmisperceivedcardiovascularriskandtherapeuticinertiaasdeterminantsoflowldlcholesteroltargetsachievementindiabetes
AT avogardoangelo physiciansmisperceivedcardiovascularriskandtherapeuticinertiaasdeterminantsoflowldlcholesteroltargetsachievementindiabetes
AT physiciansmisperceivedcardiovascularriskandtherapeuticinertiaasdeterminantsoflowldlcholesteroltargetsachievementindiabetes